4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs

ClinicalTrials.gov ID: NCT06553547

Public ClinicalTrials.gov record NCT06553547. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 19, 2026, 9:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

4-Week, Multi-Center, Randomized, Db-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety & Efficacy of Tenapanor for the T/t of IBS-C in Pts. 6 to < 12 Yrs. Old

Study identification

NCT ID: NCT06553547
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Ardelyx; Industry
Enrollment: 72 participants

Conditions and interventions

Conditions

Irritable Bowel Syndrome With Constipation (IBS-C)

Interventions

Placebo Drug
Tenapanor Drug

Drug

Eligibility (public fields only)

Age range: 6 Years to 11 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 23, 2024
Primary completion: May 31, 2026
Completion: May 31, 2026
Last update posted: May 11, 2026

2024 – 2026

United States locations

U.S. sites: 20
U.S. states: 13
U.S. cities: 18

Facility	City	State	ZIP	Site status
Applied Research Center of Arkansas	Little Rock	Arkansas	72205	Recruiting
Connecticut Children's Medical Center	Hartford	Connecticut	06106	Recruiting
Waterway Research & Associates Corp.	Miami	Florida	33155	Recruiting
Valencia Medical and Research Center	Miami	Florida	33165	Recruiting
Orlando Health, Inc.- APH Center for Digestive Health and Nutrition	Orlando	Florida	32806	Recruiting
Florida Pharmaceutical Research and Associates, Inc.	South Miami	Florida	33143	Recruiting
OSF Saint Francis Medical Center	Peoria	Illinois	61637	Recruiting
Mankato Clinic Children's Health Center	Mankato	Minnesota	56001	Recruiting
Boys Town National Research Hospital	Boys Town	Nebraska	68010	Recruiting
SUNY Downstate Medical Center	Brooklyn	New York	11203	Recruiting
Wilmington Health	Wilmington	North Carolina	28401	Recruiting
Akron Children's Hospital	Akron	Ohio	44308	Recruiting
Prisma Health Children's Hospital	Greenville	South Carolina	29615	Recruiting
Maspons Pediatric Gastro	El Paso	Texas	79902	Recruiting
Proactive El Paso, LLC	El Paso	Texas	79902	Recruiting
Texas Digestive Specialists	Harlingen	Texas	78550	Recruiting
Sun Research Institute	San Antonio	Texas	78215	Recruiting
Pioneer Research Solutions Inc	Sugar Land	Texas	77479	Recruiting
Clinical Research Partners, LLC	Richmond	Virginia	23226	Recruiting
University Physicians and Surgeons, Inc	Huntington	West Virginia	25701	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06553547, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 11, 2026 · Synced May 19, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06553547 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →